{
    "clinical_study": {
        "@rank": "149740", 
        "arm_group": [
            {
                "arm_group_label": "Functional meat", 
                "arm_group_type": "Experimental", 
                "description": "During the I period, volunteers weekly consumed three 150g/serving Functional Meat (FM) products (cooked Ham and Turkey breast). It was firmly recommended that all other meats and meat derivatives had to be excluded from the diet."
            }, 
            {
                "arm_group_label": "Control Meat", 
                "arm_group_type": "Placebo Comparator", 
                "description": "During the C period, volunteers consumed identical amounts of meat products that did not include functional ingredients (Control Meat (CM))."
            }
        ], 
        "brief_summary": {
            "textblock": "Volunteers were randomly assigned by gender to follow of two 12 weeks experimental periods:\n      intervention (I) and control (C) in different order (I/C or C/I).  Both periods were\n      separated by a 4 weeks wash-out interval during which subjects returned to their usual diet:\n\n      During the I period, volunteers weekly consumed three 150g/serving Functional Meat (FM)\n      products (cooked Ham and Turkey breast). It was firmly recommended that all other meats and\n      meat derivatives had to be excluded from the diet.\n\n      During the C period, volunteers consumed identical amounts of meat products that did not\n      include functional ingredients (Control Meat (CM)).\n\n      Functional meat (FM) products (Functional cooked Ham (FH) and Functional cooked Turkey\n      breast (FT)), were manufactured mixing the meats with the patented formula\u00ae\n      (P200402755.2004). The amount of supercritical rosemary extract, deodorized salmon oil and\n      vitamin E used was respectively, 0.02% w/w, 0.6% w/w, and 0.001% w/w.\n\n      Control meat (CM) products (Control cooked Ham (CH) and Control cooked Turkey (CT), were\n      prepared without addition of the functional ingredients."
        }, 
        "brief_title": "Health Benefits of Functional Meat (With n-3 Fatty Acids and Rosemary Extract) on Low Risk for Cardiovascular Disease People", 
        "completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "condition": "Low Risk for Cardiovascular Disease", 
        "condition_browse": {
            "mesh_term": "Cardiovascular Diseases"
        }, 
        "detailed_description": {
            "textblock": "The total duration of the study was 28 weeks: first experimental period 0-12 weeks, washout\n      period 12-16 weeks second experimental period 16-28 weeks:"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men and women aged over 18 years\n\n          -  At least 2 lipid profile parameters altered (TAG \u2265150 mg /dl  and/or total\n             cholesterol \u2265200 mg / dl  and/or LDL \u2265130 mg / dl and/or HDL \u226540mg/dl men or \u2265\n             50mg/dl women).\n\n          -  Signed informed consent\n\n        Exclusion Criteria:\n\n          -  Individuals with body mass index (BMI) \u2265 35 kg/m2\n\n          -  Individuals with Diabetes Mellitus insulin dependent\n\n          -  Individuals with disorders associated with eating behaviour\n\n          -  Individuals with consumption of omega 3 functional foods, fish oil or antioxidant\n             supplements\n\n          -  Individuals inability to consume the test foods (ej. Vegetarians)\n\n          -  Individuals with special diet due to disease as celiac disease, chronic renal\n             failure, etc.\n\n          -  Individuals with mental disease or low cognitive function.\n\n          -  Individuals with consumption of drugs to weight lost.\n\n          -  Individuals treated with drugs whose direct effect is on lipid profile (statins,\n             fibrates, diuretics, corticosteroids or oral anti-inflammatory).\n\n          -  Individuals with diseases that could be involucrate in weight lost (not controlled\n             hypothyroidism, serious psychiatric illness, etc.).\n\n          -  Pregnant women or lactating.\n\n          -  Individuals with regular consumption of anti-inflammatory or glucocorticoids."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01999088", 
            "org_study_id": "HULP-2889"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Functional meat", 
                    "Control Meat"
                ], 
                "description": "During the I period, volunteers weekly consumed three 150g/serving Functional Meat (FM) products (cooked Ham and Turkey breast). It was firmly recommended that all other meats and meat derivatives had to be excluded from the diet.", 
                "intervention_name": "Functional Meet", 
                "intervention_type": "Other", 
                "other_name": "Functional food"
            }, 
            {
                "arm_group_label": [
                    "Functional meat", 
                    "Control Meat"
                ], 
                "description": "During the C period, volunteers consumed identical amounts of meat products that did not include functional ingredients (Control Meat (CM)).", 
                "intervention_name": "Control Meat", 
                "intervention_type": "Other", 
                "other_name": "Control Food"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fatty Acids, Omega-3", 
            "Rosemary extract", 
            "Functional meat", 
            "Cardiovascular disease"
        ], 
        "lastchanged_date": "November 25, 2013", 
        "link": [
            {
                "description": "Institute for Health Research IdiPAZ", 
                "url": "http://www.idipaz.es"
            }, 
            {
                "description": "Research group in Nutrition and Functional Foods (NUTRINVEST)", 
                "url": "http://www.nutrinvest.com/"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Madrid", 
                    "country": "Spain", 
                    "state": "Maadrid", 
                    "zip": "28046"
                }, 
                "name": "Hospital Universitario La Paz"
            }
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Double-blind, Cross-over Placebo-controlled Study to Assess the Functional Meat Products With n-3 and Rosemary Extract Fluid in Biochemical Markers of Cardiovascular Disease Related Risk in Subjects at Low Risk for Cardiovascular Disease", 
        "other_outcome": [
            {
                "measure": "Homocystein levels changes", 
                "safety_issue": "No", 
                "time_frame": "0, 12, 16 and 28 week"
            }, 
            {
                "description": "Subjects were asked to value taste and smell meats consumed, using a Visual Analogical Scale ranged 1-10 cm.", 
                "measure": "Sensory perception", 
                "safety_issue": "No", 
                "time_frame": "12, and 28 week"
            }, 
            {
                "description": "Defined as any unfavourable, unintended effect reported by a subject or observed by the investigator during the study. All were recorded along with the symptoms involved (nausea, vomiting, diarrhoea, halitosis, constipation).", 
                "measure": "Adverse event", 
                "safety_issue": "Yes", 
                "time_frame": "12, and 28 week"
            }
        ], 
        "overall_official": {
            "affiliation": "Hospital Universitario La Paz", 
            "last_name": "Carmen Gomez-Candela, MD,  PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Parameters measured were: Cholesterol, LDL-Cholesterol, HDL-Cholesterol, Triglycerides, Apolipoprotein B and Apolipoprotein A.", 
            "measure": "Lipid profile changes", 
            "safety_issue": "No", 
            "time_frame": "0, 12, 16 and 28 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01999088"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Framingham score adapted to Spanish population (cardiovascular risk measurement)", 
                "measure": "Framingham score changes", 
                "safety_issue": "No", 
                "time_frame": "0, 12, 16 and 28 week"
            }, 
            {
                "description": "Parameters measured were: Adiponectin, fibrinogen, TNF\u03b1, IL6, IL1B, PAI-1 and PCR", 
                "measure": "Inflammatory markers changes", 
                "safety_issue": "No", 
                "time_frame": "0, 12, 16 and 28 week"
            }, 
            {
                "description": "Parameters measured were: plasma antioxidant capacity (FRAP, ferric reducing antioxidant power), lipidic peroxidation (TBARS, thiobarbituric acid reactive substances assay), LDL-ox, . 8-iso-Prostaglandin F2\u03b1 (8-iso-PGF2\u03b1), \u03b1-tocopherol and nitric oxide synthase (NOS).", 
                "measure": "Oxidative Stress Parameters changes", 
                "safety_issue": "Yes", 
                "time_frame": "0, 12, 16 and 28 week"
            }, 
            {
                "description": "Parameters measured were: glucose, basal insulin, HOMA index (glycemic insulin sensitivity index was calculated using the formula: HOMA-IR = fasting glucose (mmol/l)/fasting immunoreactive insulin (mU/ml)/22.5).", 
                "measure": "Glucosa Metabolism changes", 
                "safety_issue": "No", 
                "time_frame": "0, 12, 16 and 28 week"
            }, 
            {
                "measure": "Blood pressure and heart rate changes", 
                "safety_issue": "No", 
                "time_frame": "0, 12, 16 and 28 week"
            }, 
            {
                "description": "Parameters measured were: Weight, Height and waist circumference,  tricipital skinfold thickness and fat mass percentage (FM%).", 
                "measure": "Anthropometric parameters changes", 
                "safety_issue": "No", 
                "time_frame": "0, 12, 16 and 28 week"
            }
        ], 
        "source": "Instituto de Investigaci\u00f3n Hospital Universitario La Paz", 
        "sponsors": {
            "collaborator": {
                "agency": "Spanish Ministry of industry, tourism and trade", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Instituto de Investigaci\u00f3n Hospital Universitario La Paz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}